Beone Medicines Ltd. Class A · SSE:688235
Lee Chan Henry sold 332 Beone Medicines Ltd. Class A shares (Form 4)
Traded Apr 8, 2026 · Filed Apr 10, 2026
On Apr 8, 2026, Lee Chan Henry (SVP, General Counsel) sold 332 Beone Medicines Ltd. Class A shares at US$311.59 for US$103K under a trading plan, leaving 0 shares. Filed Apr 10, 2026 (Form 4).
- Sold
- 332 shares
- Price
- US$311.59
- Value
- US$103K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 8, 2026 | American Depositary Shares | Option exercise | 101 | US$194.47 | 101 | Direct |
| Apr 8, 2026 | American Depositary Shares | Option exercise | 133 | US$213.32 | 234 | Direct |
| Apr 8, 2026 | American Depositary Shares | Option exercise | 98 | US$159.03 | 332 | Direct |
| Apr 8, 2026 | American Depositary Shares | Sale | 332 | US$311.59 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Lee Chan Henry
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Lee Chan Henry · Aug 13, 2026
- Form 4 · Lee Chan Henry · Aug 3, 2026
- Form 4 · Lee Chan Henry · Jul 24, 2026
- Form 4 · Lee Chan Henry · Jul 10, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026